Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Xiamen Gelfeel Bio-Technology is a high-tech enterprise specializing in the research, development, and manufacturing of advanced biomaterials and medical devices, with a core focus on hydrogel technology. The company utilizes its proprietary Gelfeel platform to develop high-performance medical products for wound care, surgical hemostasis, and tissue engineering. Their product portfolio includes hydrogel dressings, anti-adhesion barriers, and specialized materials for regenerative medicine. By integrating material science with clinical needs, Gelfeel Bio-Technology aims to provide innovative solutions for complex surgical and dermatological applications. The company operates out of Xiamen, China, and maintains a strong emphasis on intellectual property and clinical validation for its biomaterial pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Xiamen Gelfeel Bio-Technology.